Target intelligence / Profile preview

MicroRNA 4255 (MIR4255)

Target: MIR4255
Molecular classification: MicroRNA (miRNA), Non-coding RNA

Overview

MicroRNA 4255 is a small non-coding RNA (typically 20–24 nucleotides) expressed in Homo sapiens. Like other miRNAs, it is transcribed as a precursor and processed by Drosha and Dicer enzymes into its mature form, participating in gene regulation primarily by binding to the 3' untranslated region of target messenger RNAs to suppress their expression. To date, nothing indicates it is used as a direct therapeutic target, nor are there disease or drug interactions specifically assigned to this molecule[6].

Other names: hsa-mir-4255MIR4255

Mechanism of action

Inhibition of mRNA translation Destabilization of target mRNA via RNA-induced silencing complex (RISC)

Biological functions

Post-transcriptional regulation of gene expressionRNA silencing/Regulation of mRNA stability and translation

Beyond the preview

Go deeper on MicroRNA 4255 (MIR4255).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4255 (MIR4255).

Explore the full profile